当前位置：
X-MOL 学术
›
Ann. Thorac. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Clinical trials for coronavirus disease 2019: What is being evaluated and what is not.
Annals of Thoracic Medicine ( IF 2.1 ) Pub Date : 2020-04-01 , DOI: 10.4103/atm.atm_99_20 Yaseen M Arabi 1, 2, 3 , Ayed Asseri 4 , Steve Webb 5 , John Marshall 6 , Mohamed S Al Moamary 7, 8
Since the report of the first case of coronavirus disease 2019 (COVID-19) in China in late December 2019, there have been 204 610 cases worldwide as of 18 March, 2020. As part of the response to this outbreak, there has been an impressive amount of research undertaken to better characterize the disease and to evaluate therapeutic options. By March 12, 2020, there are more than 382 studies registered in the clinical trials databases addressing COVID-19 including more than 80 randomized controlled trials.
更新日期：2020-04-01
Annals of Thoracic Medicine ( IF 2.1 ) Pub Date : 2020-04-01 , DOI: 10.4103/atm.atm_99_20 Yaseen M Arabi 1, 2, 3 , Ayed Asseri 4 , Steve Webb 5 , John Marshall 6 , Mohamed S Al Moamary 7, 8
Affiliation
Since the report of the first case of coronavirus disease 2019 (COVID-19) in China in late December 2019, there have been 204 610 cases worldwide as of 18 March, 2020. As part of the response to this outbreak, there has been an impressive amount of research undertaken to better characterize the disease and to evaluate therapeutic options. By March 12, 2020, there are more than 382 studies registered in the clinical trials databases addressing COVID-19 including more than 80 randomized controlled trials.
京公网安备 11010802027423号